ArticleJournal of obstetrics and gynaecology of India2025
Article in Journal of obstetrics and gynaecology of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitamin D receptor (VDR) regulates insulin sensitivity, lipid metabolism and hormone balance in women. There are contrasting opinions on influence of VDR gene polymorphism for PCOS predisposition. Therefore, the present study investigated associations between VDR polymorphism (FOK1 and APA1) and PCOS phenotype as well as related biochemical and clinical parameters. Methods: A total 240 female participants were enrolled in the study which consists of 120 women with PCOS and 120 control in group. We collected 5 ml of blood from each participant from which 3 ml was used for biochemical analysis and 2 ml was used to investigate genetic polymorphism in VDR genes via PCR-RFLP. Chi-square test, one-way ANOVA and Kruskal-Wallis test were used for the data analysis. Results: We found that polymorphism in FOK1 and APA1 genotypes were significantly associated with the body mass index (BMI), high-density lipoprotein (HDL), prolactin level and fasting blood sample (FBS), total cholesterol, triglyceride, HDL level respectively among PCOS patients (p-value < 0.05). Similarly, APA1 polymorphism was also associated with the hip-waist ratio, FBS, HDL, LDL and LDL/HDL ratio, estradiol and prolactin level in control group (p < 0.05). However, we didn't find any difference in the genotypic distribution of the FOK1 and APA1 gene polymorphs among the PCOS and controls group (p > 0.05). Conclusion: The polymorphism in FOK1 and APA1 genes can indirectly alter the biochemical parameter and hormonal balance in body which might contribute to the development of PCOS. Dyslipidemia and hormonal imbalance must be ruled out in relation to VDR gene polymorphism in PCOS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.